Medical Technology Commercial Architecture & Market Leadership
At Virellance Medical Technologies, Britney occupies a dual-impact leadership position at the intersection of
medical device technologies and international healthcare markets. As Product Manager and Director of Market
Analysis, she translates hospital clinical requirements and macroeconomic market trends into structured,
cost-effective equipment procurement and distribution agreements.
“By aligning quantitative econometric models with healthcare infrastructure demands, we ensure that
cutting-edge diagnostic and life-support medical technologies are distributed reliably to clinical providers worldwide.”
Her executive mandate covers the commercialization framework for Virellance's medical device suites—governing
the international sourcing, quality vetting, and hospital deployment of high-definition ultrasound systems,
multi-parameter ICU telemetry, minimally invasive surgical consoles, and critical care mechanical ventilators.
Dual-Continent Graduate Pedigree in Business & Economics
Britney’s strategic capability is rooted in an exceptional international education spanning two prominent
academic capitals:
-
Master of Business Administration (MBA) — Moscow State University (Faculty of
Business Administration): Focused on corporate governance, organizational design, and international
enterprise management.
-
Master of Economics (Three-Year Advanced Program) — Melbourne, Australia:
Concentrated on quantitative market mechanics, econometric modeling, capital allocation theory, and
behavioral finance.
Having completed her primary and secondary schooling in Moscow, Russia, she was raised in an intellectually
rigorous environment where she developed a lifelong passion for dissecting the nature of financial markets
and economic systems.
Cross-Border Healthcare Investment & U.S. Expansion
Recognizing that medical technologies and healthcare infrastructure represented the definitive frontier for
long-term value creation, Britney directed her quantitative market expertise toward precision biomedical equipment
and hospital procurement systems.
In April 2018, seeking broader opportunities for high-impact professional development, she transitioned to
the United States. Following strategic guidance and supported by family funding for her EB-5 direct
investment ($900,000 threshold verified), she obtained her visa and established her base in New York City.
In April 2020, upon approval of Form I-485, she was granted permanent residency.
Mentored by seasoned industry leaders, she launched her entrepreneurial endeavors in New York, structuring
medical device distribution networks and building the commercialization strategy that now powers Virellance
Medical Technologies.
Resilience, Philanthropy & Personal Pursuits
Britney brings profound resilience to her executive leadership. Following the loss of her husband in 2021 to
a brain tumor, she has dedicated significant personal commitment to accelerating biomedical innovation and
translational healthcare advancements that offer real, life-saving benefits to patients.
Outside of executive meetings and market analytics, Britney is actively engaged in charitable initiatives
and community wellness causes. Her personal pursuits embody discipline, athleticism, and a deep appreciation
for the outdoors:
Equestrianism
Passionate horseback rider
Alpine Skiing
High-altitude winter sports
Open-Water Diving
Marine exploration & diving
Macroeconomic Research
Financial markets & reading
